EpiPen® Jr Shortage - 20 November 2019

The supply of EpiPen® Jr 150mcg adrenaline (epinephrine) autoinjectors to Australia has been affected due to manufacturing delays from the manufacturer in the US, Meridian Medical Technologies, a Pfizer company. This means that there is currently a shortage of EpiPen® Jr as noted on the TGA website https://apps.tga.gov.au/prod/MSI/search and normal supply is expected by 31st January 2020. 

Mylan, the supplier of EpiPen® Jr and EpiPen®  in Australia, will continue to provide updates about the supply situation and their latest update for consumers can be viewed here 
(pdfConsumer notification EpiPen Jr supply constraint Nov 201991.10 KB).

Please note that supply of EpiPen® 300mcg adrenaline (epinephrine) autoinjectors is NOT affected.

Mylan has set up the following process to ensure those at risk for a potentially life-threatening allergic reaction (anaphylaxis) have access to the emergency treatment they may need:

  • Patients requiring an EpiPen® Jr are being directed to contact their local pharmacy.

  • Pharmacies can then contact the Mylan Customer Support team on 1800 274 276 or the EpiPen® Customer Service Toll Free hotline on 1800 931 625 or This email address is being protected from spambots. You need JavaScript enabled to view it.  to obtain instructions on how to access emergency supply.

See ASCIA information on use of an expired EpiPen®
www.allergy.org.au/about-ascia/info-updates/epipen-jr-supply-update

AND

www.allergy.org.au/hp/anaphylaxis/adrenaline-autoinjector-storage-expiry-and-disposal

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William


© 2023 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 



ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.